WO2024156888 - CD163-BINDING CONJUGATES
National phase entry is expected:
Publication Number
WO/2024/156888
Publication Date
02.08.2024
International Application No.
PCT/EP2024/051945
International Filing Date
26.01.2024
Title **
[English]
CD163-BINDING CONJUGATES
[French]
CONJUGUÉS DE LIAISON À CD163
Applicants **
VIB VZW
VRIJE UNIVERSITEIT BRUSSEL
Inventors
VAN GINDERACHTER, Jo
RAES, Geert
VINCKE, Cécile
DEVOOGDT, Nick
DE GROOF, Timo
LAUWERS, Yoline
Priority Data
23153695.4
27.01.2023
EP
23153700.2
27.01.2023
EP
23193741.8
28.08.2023
EP
23193745.9
28.08.2023
EP
Application details
| Total Number of Claims/PCT | * |
| Number of Independent Claims | * |
| Number of Priorities | * |
| Number of Multi-Dependent Claims | * |
| Number of Drawings | * |
| Pages for Publication | * |
| Number of Pages with Drawings | * |
| Pages of Specification | * |
| * | |
| Number of Office Actions | * |
| * | |
International Searching Authority |
EPO
* |
| Recordal of a Change of the Applicant's Name/Address |
Change of Applicant's Name and Address
* |
| Type of Assignment |
The Standard Agent's Assignment
* |
| Applicant's Legal Status |
Legal Entity
* |
| * | |
| * | |
| * | |
| * | |
| * | |
| Entry into National Phase under |
Chapter I
* |
| Patent Delivery |
Send the Letters Patent by Courier
* |
| Translation |
|
* The data is based on automatic recognition. Please verify and amend if necessary.
** IP-Coster compiles data from publicly available sources. If this data includes your personal information, you can contact us to request its removal.
Quotation for National Phase entry
| Country | Stages | Total | |
|---|---|---|---|
| China | Filing, Examination, Granting | 2312 | |
| EPO | Filing, Examination, Granting | 8623 | |
| Japan | Filing, Examination, Granting | 2183 | |
| South Korea | Filing, Examination, Granting | 2116 | |
| USA | Filing, Examination, Granting | 6540 |
Total:
21,774
The term for entry into the National Phase has expired. This quotation is for informational purposes only
Contact Us
Abstract[English]
The invention relates to polypeptides, in particular polypeptides comprising an immunoglobulin domain, binding to human and murine CD163 protein and to applications of such polypeptides such as for use as diagnostic agent, for example as an immunotracer. The invention further relates to conjugates, in particular conjugates of polypeptides comprising an immunoglobulin domain binding to human and murine CD163 protein and a further moiety, such as a therapeutic moiety, and to applications of such conjugates.[French]
L'invention concerne des polypeptides, en particulier des polypeptides comprenant un domaine d'immunoglobuline, se liant à la protéine CD163 humaine et murine et des applications de tels polypeptides, telles que pour une utilisation en tant qu'agent de diagnostic, par exemple en tant qu'immunotraceur. L'invention concerne en outre des conjugués, en particulier des conjugués de polypeptides comprenant un domaine d'immunoglobuline se liant à la protéine CD163 humaine et murine et une autre fraction, telle qu'une fraction thérapeutique, et des applications de tels conjugués.